Quantcast

Longwood Capital Partners LLC Buys ACADIA Pharmaceuticals Inc, Viveve Medical Inc, Biocryst ...


Shutterstock photo
Longwood Capital Partners LLC
  • New Purchases: VIVE , TSRO , ZGNX , VRAY, AVXS, ANAB, MDCO, EVH, NSTG, CLVS,
  • Added Positions:ACAD, BCRX, ASMB, EDGE, DBVT, IRIX, CASM, CEMI,
  • Reduced Positions:IMMU, NDRM, ACRS, VCYT, LBIO, MRVL, RARX, AUPH, OXFD, ASND,
  • Sold Out:AKBA, GWPH, WBMD, DERM, VNDA, REPH, AERI, ZBH, FOLD, SPNC,

For the details of Longwood Capital Partners LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Longwood+Capital+Partners+LLC

These are the top 5 holdings of Longwood Capital Partners LLC

  1. iShares Russell 2000 ( IWM ) - 290,000 shares, 10.74% of the total portfolio.
  2. Veracyte Inc ( VCYT ) - 3,083,559 shares, 7.63% of the total portfolio. Shares reduced by 12.23%
  3. Assembly Biosciences Inc ( ASMB ) - 1,100,000 shares, 7.56% of the total portfolio. Shares added by 12.64%
  4. Lion Biotechnologies Inc ( LBIO ) - 3,415,044 shares, 6.86% of the total portfolio. Shares reduced by 10.36%
  5. IRIDEX Corp ( IRIX ) - 1,691,865 shares, 5.41% of the total portfolio. Shares added by 8.86%


New Purchase: Viveve Medical Inc (VIVE)

Longwood Capital Partners LLC initiated holdings in Viveve Medical Inc. The purchase prices were between $3.99 and $6.33, with an estimated average price of $4.86. The stock is now traded at around $8.04. The impact to the portfolio due to this purchase was 1.94%. The holdings were 1,140,000 shares as of 2017-03-31.

New Purchase: Tesaro Inc (TSRO)

Longwood Capital Partners LLC initiated holdings in Tesaro Inc. The purchase prices were between $133.25 and $190.36, with an estimated average price of $162.81. The stock is now traded at around $145.60. The impact to the portfolio due to this purchase was 1.45%. The holdings were 35,000 shares as of 2017-03-31.

New Purchase: Zogenix Inc (ZGNX)

Longwood Capital Partners LLC initiated holdings in Zogenix Inc. The purchase prices were between $7.95 and $13.05, with an estimated average price of $10.13. The stock is now traded at around $12.70. The impact to the portfolio due to this purchase was 1.28%. The holdings were 437,113 shares as of 2017-03-31.

New Purchase: ViewRay Inc (VRAY)

Longwood Capital Partners LLC initiated holdings in ViewRay Inc. The purchase prices were between $3.04 and $9.47, with an estimated average price of $5.45. The stock is now traded at around $6.56. The impact to the portfolio due to this purchase was 1.25%. The holdings were 601,073 shares as of 2017-03-31.

New Purchase: AveXis Inc (AVXS)

Longwood Capital Partners LLC initiated holdings in AveXis Inc. The purchase prices were between $47.26 and $84, with an estimated average price of $61.9. The stock is now traded at around $76.58. The impact to the portfolio due to this purchase was 1.15%. The holdings were 56,000 shares as of 2017-03-31.

New Purchase: AnaptysBio Inc (ANAB)

Longwood Capital Partners LLC initiated holdings in AnaptysBio Inc. The purchase prices were between $16.62 and $28.78, with an estimated average price of $23.3. The stock is now traded at around $26.29. The impact to the portfolio due to this purchase was 1.12%. The holdings were 165,690 shares as of 2017-03-31.

Added: ACADIA Pharmaceuticals Inc (ACAD)

Longwood Capital Partners LLC added to the holdings in ACADIA Pharmaceuticals Inc by 90.92%. The purchase prices were between $28.77 and $39.85, with an estimated average price of $35.3. The stock is now traded at around $29.01. The impact to the portfolio due to this purchase was 2.53%. The holdings were 572,756 shares as of 2017-03-31.

Added: Biocryst Pharmaceuticals Inc (BCRX)

Longwood Capital Partners LLC added to the holdings in Biocryst Pharmaceuticals Inc by 513.54%. The purchase prices were between $5.49 and $9.2, with an estimated average price of $6.96. The stock is now traded at around $5.85. The impact to the portfolio due to this purchase was 1.74%. The holdings were 920,310 shares as of 2017-03-31.

Added: Edge Therapeutics Inc (EDGE)

Longwood Capital Partners LLC added to the holdings in Edge Therapeutics Inc by 29.92%. The purchase prices were between $7.62 and $12.99, with an estimated average price of $9.9. The stock is now traded at around $10.45. The impact to the portfolio due to this purchase was 0.76%. The holdings were 1,351,516 shares as of 2017-03-31.

Added: DBV Technologies SA (DBVT)

Longwood Capital Partners LLC added to the holdings in DBV Technologies SA by 62.89%. The purchase prices were between $33.24 and $36.97, with an estimated average price of $35.09. The stock is now traded at around $34.80. The impact to the portfolio due to this purchase was 0.55%. The holdings were 149,690 shares as of 2017-03-31.

Sold Out: Akebia Therapeutics Inc (AKBA)

Longwood Capital Partners LLC sold out the holdings in Akebia Therapeutics Inc. The sale prices were between $8.94 and $10.55, with an estimated average price of $9.76.

Sold Out: GW Pharmaceuticals PLC (GWPH)

Longwood Capital Partners LLC sold out the holdings in GW Pharmaceuticals PLC. The sale prices were between $112.38 and $132.51, with an estimated average price of $122.67.

Sold Out: WebMD Health Corp (WBMD)

Longwood Capital Partners LLC sold out the holdings in WebMD Health Corp. The sale prices were between $48.23 and $53.79, with an estimated average price of $51.08.

Sold Out: Dermira Inc (DERM)

Longwood Capital Partners LLC sold out the holdings in Dermira Inc. The sale prices were between $27.98 and $38.03, with an estimated average price of $32.26.

Sold Out: Vanda Pharmaceuticals Inc (VNDA)

Longwood Capital Partners LLC sold out the holdings in Vanda Pharmaceuticals Inc. The sale prices were between $13.05 and $15.95, with an estimated average price of $14.25.

Sold Out: Recro Pharma Inc (REPH)

Longwood Capital Partners LLC sold out the holdings in Recro Pharma Inc. The sale prices were between $6.96 and $8.74, with an estimated average price of $7.76.



Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , Stocks
Referenced Symbols: IWM , VCYT , ASMB , IRIX




More from GuruFocus

Subscribe






GuruFocus
Contributor:

GuruFocus

Stock Picks, Portfolios










Research Brokers before you trade

Want to trade FX?